Show simple item record

Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration

dc.contributor.editorKodjikian, Laurent
dc.date.accessioned2022-05-06T11:21:10Z
dc.date.available2022-05-06T11:21:10Z
dc.date.issued2022
dc.identifierONIX_20220506_9783036539300_71
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/81005
dc.description.abstractIn this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otheraflibercept monotherapy
dc.subject.otherpolypoidal choroidal vasculopathy
dc.subject.otherneovascular age-related macular degeneration
dc.subject.othergood baseline visual acuity
dc.subject.otherForeseeHome AMD Monitoring System®
dc.subject.otherAREDS2-HOME study
dc.subject.otherage-related macular degeneration
dc.subject.otherexudation
dc.subject.otheroptical coherence tomography angiography
dc.subject.otheranti-vascular endothelial growth factor
dc.subject.otherbrolucizumab
dc.subject.otherepithelial tear
dc.subject.otheroptical coherence tomography
dc.subject.otherSorsby’s fundus dystrophy
dc.subject.otherSorsby
dc.subject.otherhereditary retinal dystrophy
dc.subject.otherchoroidal neovascularisation
dc.subject.othermacular neovascularization
dc.subject.otheranti-VEGF treatment
dc.subject.otherlong-term FU
dc.subject.othertreatment outcome
dc.subject.otheremerging treatment
dc.subject.otherneovascular age-related macular degeneration (nAMD)
dc.subject.otherVascular Endothelial Growth Factor (VEGF)
dc.subject.othercataract surgery
dc.subject.otherclinical trials
dc.subject.otherreal-world evidence
dc.subject.otherAMD
dc.subject.otheroct-angiography
dc.subject.otherfellow eye
dc.subject.otherchoriocapillaris
dc.subject.otherquiescent macular neovascularization
dc.subject.otherranibizumab
dc.subject.otheraflibercept
dc.subject.otheranti-VEGF
dc.subject.othervisual acuity
dc.subject.otherreading acuity
dc.subject.otherdisease activity
dc.subject.othertreatment change
dc.subject.othertreat and extend
dc.subject.otherswitch therapy
dc.subject.otherretina
dc.subject.otherchoroidal neovascularization
dc.subject.otherangiogenesis
dc.subject.othermeteorin
dc.subject.othertherapeutic innovation
dc.subject.otherprevention
dc.subject.othernutrients
dc.subject.otherlifestyle
dc.subject.othertreatment-naive
dc.subject.otheranti–vascular endothelial growth factor
dc.subject.othercardiovascular risk factors
dc.subject.otherarterial hypertension
dc.subject.othermacula-off rhegmatogenous detachment
dc.subject.othersuperficial perifoveal capillary plexus
dc.subject.otherretinal deep perifoveal capillary plexus
dc.subject.otheridentification
dc.subject.otherrisk
dc.subject.otherDelphi
dc.subject.otherSTARS®
dc.subject.otherfood supplement
dc.subject.otherbevacizumab
dc.subject.othermeta-analysis
dc.subject.othermeta-regression
dc.subject.othern/a
dc.subject.otherage-related macular degeneration (AMD)
dc.subject.othercomparative therapies
dc.subject.othereffectiveness
dc.subject.otherintravitreal anti-vascular endothelial growth factor
dc.subject.othertreat-and-extend
dc.subject.otherpro re nata regimen
dc.titleDiagnosis, Treatment and Prevention of Age-Related Macular Degeneration
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-3929-4
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036539300
oapen.relation.isbn9783036539294
oapen.pages246
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/